BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12060639)

  • 1. Augmentation of sodium butyrate-induced apoptosis by phosphatidylinositol 3'-kinase inhibition in the KM20 human colon cancer cell line.
    Wang Q; Li N; Wang X; Kim MM; Evers BM
    Clin Cancer Res; 2002 Jun; 8(6):1940-7. PubMed ID: 12060639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrate sensitizes human colon cancer cells to TRAIL-mediated apoptosis.
    Hernandez A; Thomas R; Smith F; Sandberg J; Kim S; Chung DH; Evers BM
    Surgery; 2001 Aug; 130(2):265-72. PubMed ID: 11490359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
    Jung C; Motwani M; Kortmansky J; Sirotnak FM; She Y; Gonen M; Haimovitz-Friedman A; Schwartz GK
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6052-61. PubMed ID: 14676132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP).
    Ruemmele FM; Dionne S; Qureshi I; Sarma DS; Levy E; Seidman EG
    Cell Death Differ; 1999 Aug; 6(8):729-35. PubMed ID: 10467346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K/Akt signaling pathway in a caspase-3-dependent manner.
    Huang J; Yang M; Liu H; Jin J
    Acta Pharmacol Sin; 2008 Aug; 29(8):951-64. PubMed ID: 18664328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of alpha5 integrin decreases PI3K activation and cell adhesion of human colon cancers.
    Murillo CA; Rychahou PG; Evers BM
    Surgery; 2004 Aug; 136(2):143-9. PubMed ID: 15300173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
    Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
    Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells.
    Kim YH; Park JW; Lee JY; Kwon TK
    Carcinogenesis; 2004 Oct; 25(10):1813-20. PubMed ID: 15142888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of polyunsaturated fatty acids and sodium butyrate during apoptosis in HT-29 human colon adenocarcinoma cells.
    Hofmanová J; Vaculová A; Lojek A; Kozubík A
    Eur J Nutr; 2005 Feb; 44(1):40-51. PubMed ID: 15309463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
    Rychahou PG; Murillo CA; Evers BM
    Surgery; 2005 Aug; 138(2):391-7. PubMed ID: 16153452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L; Zhu Z; Joshi B; Porter AT; Tang DG
    Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
    Hu H; Jiang C; Ip C; Rustum YM; Lü J
    Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S; Srivastava RK
    Int J Oncol; 2007 Apr; 30(4):905-18. PubMed ID: 17332930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wortmannin enhances activation of CPP32 (Caspase-3) induced by TNF or anti-Fas.
    Fujita E; Kouroku Y; Miho Y; Tsukahara T; Ishiura S; Momoi T
    Cell Death Differ; 1998 Apr; 5(4):289-97. PubMed ID: 10200474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes.
    Drénou B; Blancheteau V; Burgess DH; Fauchet R; Charron DJ; Mooney NA
    J Immunol; 1999 Oct; 163(8):4115-24. PubMed ID: 10510346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.
    Marcelli M; Cunningham GR; Haidacher SJ; Padayatty SJ; Sturgis L; Kagan C; Denner L
    Cancer Res; 1998 Jan; 58(1):76-83. PubMed ID: 9426061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis by combined treatment with differentiation-inducing agents and interferon-alpha in human lung cancer cells.
    Yamamoto-Yamaguchi Y; Okabe-Kado J; Kasukabe T; Honma Y
    Anticancer Res; 2003; 23(3B):2537-47. PubMed ID: 12894538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis.
    Tang C; Lu YH; Xie JH; Wang F; Zou JN; Yang JS; Xing YY; Xi T
    Anticancer Drugs; 2009 Apr; 20(4):249-58. PubMed ID: 19174695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.